Drug Abuse Treatment Outcome Study - Adolescent (DATOS-A) was a multisite, prospective, community-based, longitudinal study of adolescents entering treatment. It was designed to evaluate the effectiveness of adolescent drug treatment by investigating the characteristics of the adolescent population, the structure and process of drug abuse treatment in adolescent programs, and the relationship of these factors with outcomes. Three major types or modalities of programs included in the study were chemical dependency or short-term inpatient (STI), therapeutic community or residential (RES), and outpatient drug-free (ODF). The adolescent battery of instruments included intake, intreatment, and follow-up questionnaires based largely on the DATOS adult study DRUG ABUSE TREATMENT OUTCOME STUDY (DATOS), 1991-1994: UNITED STATES instrument format, with considerable tailoring to the adolescent population. Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, such as illegal involvement, as well as information on background and demographic characteristics, education and training, mental health status, employment, income and expenditures, drug and alcohol dependence, health, religiosity and self-concept, and motivation and readiness for treatment. The one-, three-, and six-month intreatment interviews (Parts 3, 4, and 7) included items on treatment access, intreatment experience, and psychological functioning, as well as questions replicated from some of the domains in the Intake 1 and 2 questionnaires. The 12-month post-treatment follow-up interview (Part 5) included questions replicated from the previous interviews, and also included post-treatment status. Part 6 includes variables for time in treatment and interview availability indicators. The Measures Data (Part 8) were generated by using the Diagnostic and Statistical Manual of Mental Disorders (Rev. 3rd ed., DSM-III-R) (American Psychiatric Association, 1987). The variables in Part 8 give either the DSM-III-R level of dependence to a drug category or they describe whether the subject meets the DSM-III-R standard for a particular disorder. The 12-Month Follow-up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-up Interview. The urine test was used to ascertain the nature and extent of bias in the self-reports of the respondents. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, illegal methadone, sedatives and tranquilizers such as barbiturates and depressants, amphetamines or other stimulants such as speed or diet pills, methamphetamines, LSD, PCP, and other hallucinogens or psychedelics, and inhalants such as glue, gasoline, paint thinner, and aerosol sprays. The study also included drug of choice, frequency, and route of administration.

The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 1999 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Demographic data include sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.

This statistic displays the number of substance abuse treatment clients in the United States by state, as of 2020. As of that year, there were 35,874 substance abuse treatment clients located in North Carolina.

This statistic displays the number of substance abuse treatment clients in the United States by substance abuse problem from 2007 to 2020. In 2020, there were 569,522 clients in with drug abuse only in substance abuse treatment facilities.

The global substance (drug) abuse treatment market size was estimated at USD 10.25 billion in 2021 and is predicted to surpass over USD 22.9 billion by 2030 and poised to reach at a CAGR of 8.49% during the forecast period 2022 to 2030.

The Estonian Drug Treatment Database is a state register which is kept on the people who have started drug treatment. The Drug Treatment Database started its work on January 1, 2008.

Collection and processing of data on these people is necessary for getting an overview on occurrence of mental and behavioural disorders related to drug use, as well as for organising of relevant health services and planning of drug abuse preventive actions. Health care institutions holding a psychiatry authorization in Estonia present data to the database if they are turned to by a patient who is diagnosed with a mental and behavioural disorder due to drug use.

On the basis of the database's data, an annual overview is compiled, giving information about drug addicts who have turned to drug treatment in the previous calendar year, about the health service provided, the patients' socio-economic background, drug use and the related risk behaviour.

The data on the Drug Treatment Database are also submitted to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and United Nations Office on Drugs and Crime (UNODC).

In 2022, the highest number of people admitted for treatment because of substance abuse consumed cannabis, followed by opium-based substances. At the same time, 144 people were treated for cocaine consumption.

This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added. Demographic data include sex, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. This study has 1 Data Set.

The National Drug Abuse Treatment System Survey (NDATSS) provides management- and policy-relevant information about substance abuse treatment in the United States. Substance abuse treatment programs are chosen for the study by random selection from a list of all such programs, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA). Survey response rates range between 82-92%, with little to no evidence of non-response bias. The surveys are conducted by telephone. Data from Waves II through VII (1988, 1990, 1995, 2000, 2005, 2011) are currently available.

The surveys include information on (1) treatment practices; (2) patient characteristics like race, ethnicity, employment status, and patient age; (3) program characteristics like program ownership (whether it is a public, private for-profit, or private non-profit institutions) and accreditation; and (4) managerial and staff attitudes towards treatment best practices, harm reduction, and abstinence.

For those interested in data on student drug addiction in 2024, several sources offer valuable datasets and statistics.

1. Kaggle Dataset: Kaggle hosts a specific dataset on student drug addiction. This dataset includes various attributes related to student demographics, substance use patterns, and associated behavioral factors. It's a useful resource for data analysis and machine learning projects focused on understanding drug addiction among students【5†source】.

2. National Survey on Drug Use and Health (NSDUH): This comprehensive survey provides detailed annual data on substance use and mental health across the United States, including among students. It covers a wide range of substances and demographic details, helping to track trends and the need for treatment services【6†source】【8†source】.

3. Monitoring the Future (MTF) Survey: Conducted by the National Institute on Drug Abuse (NIDA), this survey tracks drug and alcohol use and attitudes among American adolescents. It provides annual updates and is an excellent source for understanding trends in substance use among high school and college students【7†source】.

4. Australian Institute of Health and Welfare (AIHW): For those interested in a more global perspective, the AIHW offers data from the National Drug Strategy Household Survey, which includes information on youth and young adult drug use in Australia. This can be useful for comparative studies【10†source】.

For detailed datasets and further analysis, you can explore these resources directly:

• Kaggle Student Drugs Addiction Dataset
• NSDUH Data
• Monitoring the Future
• AIHW Drug Survey

Database of the nation''s substance abuse and mental health research data providing public use data files, file documentation, and access to restricted-use data files to support a better understanding of this critical area of public health. The goal is to increase the use of the data to most accurately understand and assess substance abuse and mental health problems and the impact of related treatment systems. The data include the U.S. general and special populations, annual series, and designs that produce nationally representative estimates. Some of the data acquired and archived have never before been publicly distributed. Each collection includes survey instruments (when provided), a bibliography of related literature, and related Web site links. All data may be downloaded free of charge in SPSS, SAS, STATA, and ASCII formats and most studies are available for use with the online data analysis system. This system allows users to conduct analyses ranging from cross-tabulation to regression without downloading data or relying on other software. Another feature, Quick Tables, provides the ability to select variables from drop down menus to produce cross-tabulations and graphs that may be customized and cut and pasted into documents. Documentation files, such as codebooks and questionnaires, can be downloaded and viewed online.

The report looks at addiction and dependence in the areas of illegal drugs, alcohol and tobacco in Austria. The aim is to answer the following questions: How many and which people are affected by addiction and which consumption behaviour prevails? The report combines numerous data sources such as data from treatment facilities and statistics on causes of death.
https://jasmin.goeg.at/1925/2/Epidemiologiebericht%20Sucht_2021_Annex_bf.pdf

The National Registry for the Treatment of Drug Users (NRLUD) is a registry focused on the collection of data on patients entering and exiting addiction treatment, including contact, counseling and resocialization programs for drug users, i.e. data collection, verification, storage, protection and processing. This register provides summary data for statistical overviews at both national and international levels, as well as for epidemiological studies and health research. The data will be used in the creation of the drug policy and strategy of the Czech Republic and in the international context as well as in the EU.

The treatment request indicator is one of the five key indicators of drug epidemiology established by the European Monitoring Center for Drugs and Drug Addiction (hereafter EMCDDA), the collection of which is imposed on EU member states in Article 5 of Regulation (EC) No. 1920/2006 of the European Parliament and of the Council on December 12, 2006. The monitoring of treatment requests is part of the Drug Information System, the implementation of which is envisaged by a number of government resolutions on national drug policy strategies and their action plans, currently on the National Drug Policy Strategy for the period 2010–2018 and the action plan for the period 2010–2012. Treatment together with social reintegration and harm reduction, i.e. reducing the negative consequences of drug use, are two of the four pillars of the Czech anti-drug strategy. Without monitoring developments in the provision of treatment and specialized services to drug users, developments in these areas of drug policy cannot be monitored and evaluated.

Statistical unit of inquiry: A statistical unit is a person with problems caused by the use of addictive substances or a person addicted to them who entered or was included in a program aimed at counseling and addiction treatment carried out by treatment and counseling facilities.

The Uniform Facility Data Set (UFDS), formerly the National Drug and Alcohol Treatment Unit Survey or NDATUS, was designed to measure the scope and use of drug abuse treatment services in the United States. The survey collects information from each privately- and publicly-funded facility in the country that provides substance abuse treatment as well as from state-identified facilities that provide other substance abuse services. Data are collected on a number of topics including facility operation, services provided (assessment, therapy, testing, health, continuing care, programs for special groups, transitional services, community outreach, ancillary), type of treatment, facility capacity, numbers of clients, and various client characteristics. The main objective of the UFDS is to produce data that can be used to assess the nature and extent of substance abuse treatment services, to assist in the forecast of treatment resource requirements, to analyze treatment service trends, to conduct national, regional, and state-level comparative analyses of treatment services and utilization, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its on-line equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov. Additionally, the UFDS provides information that can be used to design sampling frames for other surveys of substance abuse treatment facilities.This study has 1 Data Set.

record abstracts Several limitations to the data exist and should be noted: The number and client mix of TEDS records depends, to some extent, on external factors, including the availability of public funds. In states with higher funding levels, a larger percentage of the substance-abusing population may be admitted to treatment, including the less severely impaired and the less economically disadvantaged.; The primary, secondary, and tertiary substances of abuse reported to TEDS are those substances that led to the treatment episode, and not necessarily a complete enumeration of all drugs used at the time of admission. ; The way an admission is defined may vary from state to state such that the absolute number of admissions is not a valid measure for comparing states. ; States continually review the quality of their data processing. As systematic errors are identified, revisions may be enacted in historical TEDS data files. While this process improves the dataset over time, reported historical statistics may change slightly from year to year. ; States vary in the extent to which coercion plays a role in referral to treatment. This variation derives from criminal justice practices and differing concentrations of abuser subpopulations. ; Public funding constraints may direct states to selectively target special populations, for example, pregnant women or adolescents. ; TEDS consists of treatment admissions, and therefore may include multiple admissions for the same client. Thus, any statistics derived from the data will represent admissions, not clients. It is possible for clients to have multiple initial admissions within a state and even within providers that have multiple treatment sites within the state. TEDS provides a national snapshot of what is seen at admission to treatment, but is currently not designed to follow individual clients through a sequence of treatment episodes. ; TEDS distinguishes between "transfer admissions" and "initial admissions." Transfer admissions include clients transferred for distinct services within an episode of treatment. Only initial admissions are included in the public-use file. ; Some states have no Opioid Treatment Programs (OTPs) that provide medication-assisted therapy using methadone and/or buprenorphine. ; In 2012, a new variable was added that reports the number of times, if any, that a client was arrested in the 30 days preceding his or her admission into treatment. The variable is not on files prior to 2008. In 2012, changes were made to the full TEDS series. The changes consisted of the following: The recoding scheme of the variable DENTLF (Detailed Not in Labor Force Category) was changed. The cases for "Inmate of Institution" have been separated from "Other" and are now a standalone category. ; The recoding scheme of the variable DETCRIM (Detailed Criminal Justice Referral) was changed. The cases for "Prison" have been separated from "Probation/Parole" and are now a standalone category. The same was done for the cases for "Diversionary Program" which were previously combined with "Other". But the cases for "Other Recognized Legal Entity" previously combined with "State/Federal Court, Other Court" have now been combined with the "Other" category. ; In 2011, a change was made to the full TEDS series. All records for which the age is missing are now excluded from the dataset. In 2010, changes were made to the full TEDS series. The changes consisted of the following: Clients 11 years old and younger are excluded from the dataset. ; Puerto Rico now has its own category for Census Region and Division. Clients in Puerto Rico were formerly classified into the South Census Region and South Atlantic Census Division.; The state FIPS (STFIPS) variable is retained and a second state variable was dropped to reduce redundancy.; Value labels and question text are better aligned with the TEDS State Instruction Manual for Admissions Data.; The variable RACE is no longer recoded. Codes for "Asian" (code 13) and "Native Hawaiian or Pacific Islander" (code 23) are now retained. Previously these codes were combined into the single code "Asian or Pacific Islander" (code 3). Each state may report any of the three codes. Therefore, all three codes remain in the data, unchanged from the way they are collected by the states.; The categories and codes in this public-use file differ somewhat from those used by SAMHSA and those found in the TEDS Crosswalks and in other reports. This is a result of the recoding that was performed to protect client privacy in creating the public-use file. To further protect respondent and provider privacy, all Behavioral Health Services Information System (BHSIS) unique identification numbers have been removed from the public-use data. Therefore, no linkages are possible between the TEDS and the National Survey of Substance Abuse Treatment Services (N-SSATS) public-use files. The data are collected from the states by Synectics for Management De...

This statistic displays the total number of clients in U.S. substance abuse treatment facilities from 2007 to 2020. In 2020, there were 1,090,357 clients in local, county, or community government run substance abuse treatment facilities.

Compares state and national rates of alcohol, tobacco, and other drug use and presents estimates of substance abuse treatment need. The report also provides statewide, regional, and county-level data on substance abuse consequences and the number of individuals served in Division of Alcohol and Drug Abuse treatment programs.

From 2023 to 2024, around *** percent of college and university students who received mental health services had received treatment for drug and alcohol use. This statistic shows the percentage of college and university students in the U.S. who received mental health services and received treatment for alcohol or drug use from 2010 to 2024.

In 2023, private facilities accounted for over 90 percent of the total substance abuse treatment facilities in the U.S. These were split roughly evenly between private for-profit and private nonprofit facilities. This statistic displays the distribution of substance abuse treatment facilities in the United States by ownership of 2023.

The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.